Ned is a senior editor for BioPharma Dive. Before joining Industry Dive, Ned covered economic news for a Japanese newswire and contributed articles on political risk for Global Risk Insights. He has a B.A. from the College at Georgetown University. Hoya Saxa.
1623 articles by Ned Pagliarulo
-
Gilead working to quickly boost production of experimental coronavirus drug
April 6, 2020 -
Incyte, Novartis to test repurposed cancer drug in COVID-19
April 3, 2020 -
Amgen, partnering with Seattle's Adaptive, begins coronavirus drug search
April 2, 2020 -
Amarin shares slump as surprising court defeat puts Vascepa at risk
March 31, 2020 -
No sanctions for Novartis as FDA ends review of gene therapy violations
March 30, 2020 -
FDA clears emergency use of malaria pills to treat COVID-19
March 30, 2020 -
For CAR-T, coronavirus brings uneven impact to studies, treatment
March 27, 2020 -
AstraZeneca turns again to UK's Silence in renewed RNAi push
March 25, 2020 -
Coronavirus forces ASCO, cancer research's top meeting, to move online
March 24, 2020 -
Gilead, flooded with requests, suspends access to experimental coronavirus drug
March 23, 2020 -
Drugmakers boost production of malaria pill touted by Trump as coronavirus treatment
March 20, 2020 -
Despite 'heroic' effort, coronavirus study finds little benefit to repurposed HIV drug
March 18, 2020 -
Sage redraws its plans for failed antidepressant drug
March 18, 2020 -
Pharma salesforces brought to a halt as coronavirus shutters economy
March 17, 2020 -
Germany's CureVac, the subject of a reported US overture, thrust into coronavirus spotlight
March 16, 2020 -
With AbCellera deal, Lilly becomes latest pharma to start coronavirus program
March 13, 2020 -
CureVac CEO replaced in midst of biotech's coronavirus push
March 12, 2020 -
Facing coronavirus risk, a top cancer group postpones annual meeting
March 11, 2020 -
2 newer multiple myeloma drugs fall short in bid for wider market
March 10, 2020 -
As US coronavirus cases mount, top drugmakers tell employees to work from home
March 9, 2020 -
Coronavirus spread threatens spring slate of medical meetings
March 6, 2020 -
A closer look at the Ebola drug that's become the top hope for a coronavirus treatment
March 5, 2020 -
In a CRISPR first, Editas therapy used to fix genes in the body
March 4, 2020 -
High prices fuel pharma profits. New research provides more context
March 3, 2020 -
Sanofi wins US approval for myeloma drug key to its cancer ambitions
March 2, 2020